Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
    • IPOs
  • InderesTV
  • Forum
  • Discovery
  • Om os
    • Fulgte selskaber
    • Team
Analytikerkommentar

Remedy finds good strategic partner for Control 2

Af Atte RiikolaAnalytiker
Remedy Entertainment

Translation: Original comment published in Finnish on 8/30/2024 at 7:17 am EEST.

Remedy announced on Thursday a strategic partnership agreement with Annapurna Pictures for Control 2. Remedy will self-publish the game, but Annapurna will fund 50% of the game and have the rights to extend the Control and Alan Wake brands into film and television. In our projections, we had assumed that Remedy would fund Control 2 entirely on its own and raise additional funds to do so. The current agreement is more balanced from a risk perspective and eliminates the need for additional funding that we had anticipated. At the same time, the deal offers good royalty potential and a low-risk opportunity to reach new audiences through movies and TV series. Overall, we view the deal as good for Remedy and will update our forecasts accordingly in the near future.

The deal appears to offer a balanced risk/reward for Remedy

Under the terms of the agreement, Annapurna will fund 50% of the development budget for Control 2 and will have the rights to extend the Control and Alan Wake franchises into film and television. We expect the budget for the game to remain as previously announced (50 MEUR).

Remedy and Annapurna will split the game's revenue equally until the game's production budget is recouped. Remedy will then receive a larger share of game sales, since as the publisher of the game, the company is also responsible for marketing costs (at least 10-30% of the production budget for a typical AAA game). Thus, Remedy's share after recouping the development budget could be estimated at around 60-75% of sales revenues. In return, Annapurna will receive a greater share of audiovisual productions in which Remedy does not have to invest capital.

As part of the agreement, Annapurna will acquire an option to the television and film rights to Control and Alan Wake, as well as selected audiovisual licensing rights and related ancillary products. Remedy retains all intellectual property rights to Control and Alan Wake. As a result, Remedy has complete freedom to decide the fate of a potential Control 3 game project. Annapurna seems to be a quality producer of movies and TV series, so Remedy's game brands seem to be in good hands from that perspective.

Presumably, the signing of the contract will result in a higher volume of development fees for Q3 in proportion to the development done so far on Control 2. Considering this and future development fees, Remedy's cash position (Q2'24: 26.1 MEUR) appears to be sufficient to finance the next projects and to pay the two remaining installments for the Control rights to 505 Games.

Condor will apparently also be self-published

Based on the wording of the press release "self-publishing selected titles", Remedy will also self-publish Condor. We had expected Remedy to co-publish the project with a partner. In light of the Annapurna agreement, we continue to see the possibility that Condor will also bring in a partner in some form to share the financial risk. An interesting option, we think, would be to work with Sony or Microsoft. In this case, Condor could be immediately introduced to the masses on subscription services for these platforms (PlayStation Plus / Game Pass), Remedy would receive some compensation for this and Condor would potentially get a flying start in terms of player numbers.

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Læs mere på virksomhedsside

Key Estimate Figures11.08.2024

202324e25e
Omsætning33,952,852,1
vækst-%-22,2 %55,6 %-1,4 %
EBIT (adj.)-28,6-2,6-8,9
EBIT-% (adj.)-84,4 %-5,0 %-17,0 %
EPS (adj.)-1,68-0,14-0,52
Udbytte0,000,000,00
Udbytte %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.132,0neg.

Forumopdateringer

Man kunne for en gangs skyld prøve en co-op multiplayer shooter.
for 6 timer siden
af Monopoly_of_bees
7
Er dette Control Resonant ikke netop et spring til et nyt spilkoncept, et melee-baseret action-rollespil (RPG)? Det har færdighedstræer og det...
i går
af TechLead
16
Aktieselskaber skal tjene penge, og det er ikke lykkedes her, så kursfaldet er fuldt berettiget. Der er meget lidt tro på, at det vil lykkes...
i går
af Mickwitz
0
Det var et dårligt show, og Resonantia blev ikke vist, så vi må se, hvor vi hører mere om det.
i går
af Hasty
4
Efter den tidligere CEO’s sidste år er det godt, hvis CEO’en fokuserer på at handle i stedet for at tale. Fra CEO’ens perspektiv bør han sætte...
25.3.2026, 08.06
17
Aktien er faktisk faldet -25% ÅTD, selvom en vigtig stor udgivelse er lige rundt om hjørnet… Den nye CEO, Jean-Charles Gaudechon, holder i hvert...
24.3.2026, 14.19
af Garda
5
Som nævnt har aktien faldet en del for nylig. Samtidig er Rememys vigtigste spil lige om hjørnet, hvilket fik mig til at tænke, at det kunne...
24.3.2026, 14.00
af Hasty
11
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.